TrialClinical nephrology2013

Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.

What the trial testedas reported · 10,151 people · 2013

Range includes no effect

+1%−9% to +13%

Smaller than almost all for all-cause mortality

As reported

HR 1.01, 95% CI 0.91–1.13 · the paper's word: All-cause mortality

the abstract, start to end

… vs. 15.8 per 100, hazard ratio (HR) 1.01, 95% CI 0.91 - 1.13, p = 0.82) …

← favours treatmentfavours comparator →

could be chance

All-cause mortality

HR 1.010.91–1.13

StatinsAll-cause mortality

Statins × all-cause mortalityhelps?mixed

unlikelylikely

0.500.50 without it

← favours treatmentfavours comparator →

this papermore certainless certain

1 / 5

2013

2014

2015

2016

2017

2018

2019

2020

this paperpooled itcites it